Preface to the symposium in writing on therapeutic cancer vaccines O. J. Finn SYMPOSIUM IN WRITING Pages: 125 - 125
Carcinoembryonic antigen as a target for cancer vaccines James W. HodgeJ. Schlom SYMPOSIUM IN WRITING Pages: 127 - 134
Oncogene products represent potential targets of tumor vaccines T. M. Tuttle SYMPOSIUM IN WRITING Pages: 135 - 141
Making the most of mucin: a novel target for tumor immunotherapy Simon M. Barratt-Boyes SYMPOSIUM IN WRITING Pages: 142 - 151
Carbohydrate antigens as targets for active specific immunotherapy Govindaswami Ragupathi SYMPOSIUM IN WRITING Pages: 152 - 157
Gene-modified tumor cells as cellular vaccine Sivasubramanian Baskar SYMPOSIUM IN WRITING Pages: 165 - 173
Active specific immunotherapy with hapten-modified autologous melanoma cell vaccine Takami Sato SYMPOSIUM IN WRITING Pages: 174 - 179
Treatment of malignancy by direct gene transfer of a foreign MHC class I molecule L. A. DeBruyne SYMPOSIUM IN WRITING Pages: 180 - 189
Immunogenicity increase of autologous tumor cell vaccines by virus infection and attachment of bispecific antibodies Claudia HaasV. Schirrmacher SYMPOSIUM IN WRITING Pages: 190 - 194
